June 02, 2016

Honeywell Announces New Canadian Distributor For Its Research Chemicals Business

Canada’s Leading Supplier of Chromatography, Dissolution and Spectroscopy Essentials Expands its Analytical Chemistry Portfolio with Honeywell

SEELZE, Germany, May 31, 2016 — Honeywell (NYSE: HON) announced today it has expanded its distributor network for its portfolio of inorganics, solvents and other essential research chemicals for academic, pharmaceutical and industrial laboratories.

Canadian Life Science, Canada’s leading supplier of chromatography, dissolution and spectroscopy essentials, has become an authorized distributor for Honeywell’s analytical chemistry portfolio in Canada. That portfolio includes Honeywell’s Burdick & Jackson® brand, as well as the Fluka®, Hydranal® and Chromasolv® brands, which Honeywell acquired from Sigma-Aldrich in 2015, broadening its portfolio of research chemicals.

Headquartered in Peterborough, Ontario, Canadian Life Science has been an established technology distributor of LC and GC columns, sample handling, sample preparation, dissolution, solvents and accessories since 1997. The company provides a consolidated supply of chromatography columns and accessories from world-class scientific companies.

“We are pleased with Canadian Life Science’s decision to represent Honeywell in Canada and look forward to growing our partnership,” said Boris Eterovic, director of sales for the Americas for Honeywell’s research chemicals portfolio. “Canadian Life Science is well known for quality service and support to laboratory instrument users.  Their expertise will assist us in extending our solvents to existing customers and will provide us with access to new opportunities within the Canadian market.”

Canadian Life Science’s President Kick van Lunenburg stated, “We are excited to become a distribution partner for a recognized leader like Honeywell.  “Their extended portfolio of research chemical products is well positioned for the analytical solvent market serving the pharmaceutical, biopharmaceutical, food & beverage, toxicology and environmental laboratory market segments, as well as the inorganic chemistry market segment.”

Honeywell’s research chemicals portfolio is part of the Fine Chemicals business which supplies high-quality research chemicals and specialty organic and inorganic compounds to the chemical and pharmaceutical industries. With the Riedel-de Haën® brand, Honeywell has been a respected pioneer in inorganics, solvents and other essential chemicals for over 200 years.  Its chemical products are used in a variety of laboratory, consumer and industrial applications including drug discovery, toothpaste, water purification, fortified foodstuffs, polymer synthesis, and metal surface treatment and finishing.  It maintains laboratories and production facilities in Muskegon, Michigan, USA and Seelze, Germany. To learn more about Honeywell’s research chemicals portfolio, visit www.lab-honeywell.com.

Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes, and industry; turbochargers; and performance materials. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.

Contact:
Leslie A Strazzullo
+39 345 5987100
Leslieann.strazzullo@honeywell.com